United States flu vaccine market is expected to reach nearly US$ 3 Billion by 2024.   Growth in US flu vaccine market can be attributed to factors such as increased disease awareness, expanded recommendations by governmental and advisory bodies to be vaccinated against flu vaccine and introduction of quadrivalent flu vaccine. Complete Report @ http://www.dpiresearch.com/report-details.php?P_ID=110 Long–term